BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31552873)

  • 1. "Real world survey" of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients.
    Chen JB; Kong XF; Lv YY; Qin SC; Sun XJ; Mu F; Lu TY; Xu KC
    Med Gas Res; 2019; 9(3):115-121. PubMed ID: 31552873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study.
    Chen JB; Kong XF; Qian W; Mu F; Lu TY; Lu YY; Xu KC
    Med Gas Res; 2020; 10(4):149-154. PubMed ID: 33380580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer.
    Chen JB; Kong XF; Mu F; Lu TY; Lu YY; Xu KC
    Med Gas Res; 2020; 10(2):75-80. PubMed ID: 32541132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-flow hydrogen inhalation might suppresses the immune function of middle-aged participants: a self-controlled study.
    Chen JB; Kong XF; Mu F
    Med Gas Res; 2021; 11(1):12-17. PubMed ID: 33642332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen Gas Inhalation Treatment in Acute Cerebral Infarction: A Randomized Controlled Clinical Study on Safety and Neuroprotection.
    Ono H; Nishijima Y; Ohta S; Sakamoto M; Kinone K; Horikosi T; Tamaki M; Takeshita H; Futatuki T; Ohishi W; Ishiguro T; Okamoto S; Ishii S; Takanami H
    J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2587-2594. PubMed ID: 28669654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of inhaled HYdrogen on neurological outcome following BRain Ischemia During post-cardiac arrest care (HYBRID II trial): study protocol for a randomized controlled trial.
    Tamura T; Hayashida K; Sano M; Onuki S; Suzuki M
    Trials; 2017 Oct; 18(1):488. PubMed ID: 29058596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.
    Larkin J; Lao CD; Urba WJ; McDermott DF; Horak C; Jiang J; Wolchok JD
    JAMA Oncol; 2015 Jul; 1(4):433-40. PubMed ID: 26181250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer.
    Xiong LL; Hwang JH; Huang XB; Yao SS; He CJ; Ge XH; Ge HY; Wang XF
    JOP; 2009 Mar; 10(2):123-9. PubMed ID: 19287104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients.
    Aoki T; Akiba T; Nishiyama J; Tajiri S; Hayama N; Takahashi G; Tanaka J; Sato M; Takiguchi H; Tomomatsu H; Tomomatsu K; Takihara T; Niimi K; Oguma T; Kohno M; Masuda R; Urano T; Itoh H; Kajiwara H; Nakamura N; Kunieda E; Matsumae M; Iwazaki M; Asano K
    Respir Res; 2019 Nov; 20(1):263. PubMed ID: 31752884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study.
    Luo H; Gong L; Zhu B; Huang Y; Tang C; Yu S; Yang Z; Zhou X
    Biomed Pharmacother; 2016 Dec; 84():987-993. PubMed ID: 27764762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
    Penson RT; Huang HQ; Wenzel LB; Monk BJ; Stockman S; Long HJ; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Method M; Michael H; Tewari KS
    Lancet Oncol; 2015 Mar; 16(3):301-11. PubMed ID: 25638326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of hydrogen as a new medical therapy.
    Zhang JY; Liu C; Zhou L; Qu K; Wang R; Tai MH; Lei Lei JC; Wu QF; Wang ZX
    Hepatogastroenterology; 2012 Jun; 59(116):1026-32. PubMed ID: 22328284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.